Medicare finalizes new drug pricing model for office-administered medications
The Hill · October 1, 2026Original source ↗
What happened
The Trump administration has introduced the final version of a Medicare payment model designed to adjust the prices of drugs administered in doctors' offices. The new model aims to bring these prices in line with those paid in other countries.
Why it matters
This change may impact drug costs for patients receiving treatments in outpatient settings.
How this story affects people
How does this story affect you if you receive outpatient treatments?
This change could lower the costs of medications you receive in a doctor's office, making treatments more affordable. Patients may benefit from prices that align more closely with those in other countries.
Want this written about you?
The breakdown above is the shared version, for kinds of people. In the app, Ripple uses your job, your city, and your family, then writes that part about you.
Get your Ripple